CVS Health FY2027 EPS Estimate Raised by Leerink Partnrs

CVS Health Co. (NYSE:CVS - Free Report) - Equities researchers at Leerink Partnrs increased their FY2027 earnings per share (EPS) estimates for shares of CVS Health in a note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst M. Cherny now anticipates that the pharmacy operator will earn $8.23 per share for the year, up from their previous estimate of $8.16. Leerink Partnrs currently has a "Strong-Buy" rating on the stock. The consensus estimate for CVS Health's current full-year earnings is $5.14 per share. Leerink Partnrs also issued estimates for CVS Health's FY2028 earnings at $9.36 EPS.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%.

Several other equities analysts have also issued reports on CVS. Piper Sandler cut their price target on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Edward Jones upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. StockNews.com raised shares of CVS Health from a "sell" rating to a "hold" rating in a report on Thursday. Evercore ISI boosted their target price on CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research note on Monday, January 27th. Finally, Truist Financial lifted their price objective on CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a report on Thursday. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $70.28.

Remove Ads

CVS Health Price Performance

CVS traded down $0.67 during midday trading on Friday, hitting $65.71. The company had a trading volume of 10,208,186 shares, compared to its average volume of 12,149,901. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company has a market capitalization of $82.84 billion, a PE ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The firm's 50-day simple moving average is $51.11 and its 200-day simple moving average is $55.99. CVS Health has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health's payout ratio is 72.68%.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the 3rd quarter worth approximately $25,000. Ridgewood Investments LLC lifted its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new stake in CVS Health during the 4th quarter worth approximately $28,000. Hopwood Financial Services Inc. bought a new position in CVS Health during the fourth quarter worth about $29,000. Finally, Livelsberger Financial Advisory bought a new position in CVS Health during the third quarter worth about $31,000. Institutional investors own 80.66% of the company's stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.